Official 2022 Partners
Find out more about the partners we have confirmed for the in-person 4th Annual Longevity Therapeutics Summit. Get in touch if you would like to partner and learn more about our bespoke sponsorship opportunities.
Founded in 2016, Maxwell Biosciences is a preclinical drug platform company which develops biomimetic therapeutics – synthetic compounds that mimic and improve upon biomolecules. Inspired by nature, these low-molecular weight compounds imitate key components of the immune system and are created by Maxwell’s first-in-class, CLAROMER™ brand drug platform. Many studies prove CLAROMERS™ efficacy in destroying viruses, bacteria, fungi and some cancers, while safely avoiding healthy cells. Maxwell’s technology is protected by granted patents and the company is led by a world-class team of experienced life science executives.